Bill Text - HB1349 (2024)

Relative to generalized anxiety disorder as a qualifying condition for the therapeutic cannabis program.


Revision: Sept. 21, 2023, 8:57 a.m.

 

2024 SESSION

24-2196.0

02/05

 

HOUSE BILL [bill number]

 

AN ACT relative to generalized anxiety disorder as a qualifying condition for the therapeutic cannabis program.

 

SPONSORS: [sponsors]

 

COMMITTEE: [committee]

 

─────────────────────────────────────────────────────────────────

 

ANALYSIS

 

This bill adds generalized anxiety disorder as a qualifying medical condition for the use of therapeutic cannabis.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

24-2196.0

02/05

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Four

 

AN ACT relative to generalized anxiety disorder as a qualifying condition for the therapeutic cannabis program.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  New Subparagraph; Use of Cannabis for Therapeutic Purposes; Qualifying Medical Condition; Generalized Anxiety Disorder.  Amend RSA 126-X:1, IX(b) by inserting after subparagraph (6) the following new subparagraph:

(7)  Generalized anxiety disorder.

2  Effective Date.  This act shall take effect 60 days after its passage.